Real Case Presentation &Interactive Live Discussion with Speakers & Panelists

• Date :
• 0    
  0

MSD Symposium

• Date :
• 0    
  0

Novartis Sponsored Lecture

• Date :
• 0    
  0

TBA EVA Symposium

• Date :
• 0    
  0

What is best approach for TNBC patient after achieving pCR

• Date :
• 0    
  0

Proffered Paper oral presentations

• Date :
• 0    
  0

Real Case Presentation & Interactive Live Discussion with Speakers & Panelists

• Date :
• 0    
  0

BRCA Mutation in metastatic TNBC Patient

• Date :
• 0    
  0

Treatment of metastatic TNBC

• Date :
• 0    
  0

Management of breast recurrences

• Date :
• 0    
  0

Percision Medicine Optimizing the Patients Treatment

• Date :
• 0    
  0

Pfizer Symposium

• Date :
• 0    
  0

Takeda Symposium

• Date :
• 0    
  0

Interactive Discussion with all the speakers & panelists

• Date :
• 0    
  0

Real Case Presentation & Interactive Live Discussion with Speakers & Panelists

• Date :
• 0    
  0

Systemic Management of leptomeningeal metastasis Is therea solution for this

• Date :
• 0    
  0

Her2 Low Breast Cancer

• Date :
• 0    
  0

Is Chemotherapy only a treatment of last resort in Luminal BC

• Date :
• 0    
  0

PD-L1/TILs/TMB in Immunotherapy

• Date :
• 0    
  0

Promises and limitations of Immunotherapy for NSCLC

• Date :
• 0    
  0

IO in Neoadjuvant Breast Cancer :Be Careful

• Date :
• 0    
  0

Important lessons from TAILORX, MINDACT and RX-PONDER:

• Date :
• 0    
  0

Predicting prognosis and benefit from CDK4/6 inhibitors in breast cancer usingbiology-based data

• Date :
• 0    
  0

Emerging evidence on the role of CDK4/6 inhibitors in early BC

• Date :
• 0    
  0

Treatment decision making in first line metastatic ER+/Her2- BC

• Date :
• 0    
  0

The best sequence of endocrine treatment in metastatic luminal Breast Cancer:solving the puzzle

• Date :
• 0    
  0

Challenging in Oncology Management during COVID-19 era and its Vaccination

• Date :
• 0    
  0

IO better | Prof. Edith Perez

• Date :
• 0    
  0

PARP inhibitors better | Prof. Sana Al-Sukhun

• Date :
• 0    
  0

Improving outcomes in BRCA associated Breast Cancer

• Date :
• 0    
  0

Management of Her2 + ve EBC patients

• Date :
• 0    
  0

Management of patients after adjuvant Truztuzumab and pertuzumab

• Date :
• 0    
  0

Updates in Her2 +ve target therapy in advanced breast cancer

• Date :
• 0    
  0

Management of axilla after neo-adjuvant treatment

• Date :
• 0    
  0

14eme Rencontre Solipam 2024

• Date :
• 3268    
  0

Groupe d'Etude sur la Ménopause et le vieillissement Groupe d'Etude sur la Ménopause et le vieillissement Hormonal GEMVI 2024 GEMVI 2024

• Date :
• 4336    
  0

45emes Journées de la Société Française de Sénologie et de Pathologie Mammaire - SFSPM 2024

• Date :
• 6876    
  0

XXVIIes Journées de Sénologie Interactives

• Date :
• 5366    
  0

26ème congrès GENESIS

• Date :
• 9997    
  0